Literature DB >> 25852298

Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features.

Tsan-Chieh Liao1, Chien-An Liu1, Nai-Chi Chiu1, Yi-Chen Yeh1, Yi-You Chiou1.   

Abstract

Primary lymphoepithelioma-like carcinoma in the liver is extremely rare. A few cases of lymphoepithelioma-like cholangiocarcinoma have been reported, but few radiologic features were described. We reviewed 23 cases of lymphoepithelioma-like cholangiocarcinoma reported between 1996 and 2014 and describe a rare case of a 35-year-old woman in our hospital who was diagnosed with lymphoepithelioma-like cholangiocarcinoma of the liver and was a hepatitis B carrier. The tumor (1.6 cm) in our patient appeared to be hypoechoic in sonographic images and hypodense in computed tomography (CT) images. In addition, it was homogeneous hypointense in T1-weighted magnetic resonance (MR) images (MRI) and hyperintense in T2-weighted MRI. Dynamic gadolinium-enhanced MRI showed typical image pattern of hepatocellular carcinoma (HCC). The patient underwent a laparoscopic left hepatic lobectomy, and the resected tumor consisted of well-differentiated glandular cells with extensive lymphocytic infiltration that were immunoreactive to CK (AE1/AE3), CD3, and CD20. In addition, the tumor was positive for Epstein-Barr virus-encoded RNA in situ hybridization. Finally, lymphoepithelioma-like cholangiocarcinoma was diagnosed. In previous studies, the incidence is highest among middle-aged people. Most tumors appeared to be hypodense with either hypovascular or hypervascular patterns in CT images. This case report is the first study to address sonography, CT, and MRI observations and delineate pathologic correlations. We suggest that the imaging pattern of lymphoepithelioma-like cholangiocarcinoma, either the typical cholangiocarcinoma pattern or a mimic of HCC, should be considered in the differential lists for HCC.

Entities:  

Keywords:  Epstein-Barr virus; Hepatocellular carcinoma; Lymphoepithelioma-like carcinoma; Lymphoepithelioma-like cholangiocarcinoma; Magnetic resonance imaging

Mesh:

Substances:

Year:  2015        PMID: 25852298      PMCID: PMC4385560          DOI: 10.3748/wjg.v21.i13.4089

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Intrahepatic cholangiocarcinoma with lymphoepithelioma-like component.

Authors:  T C Chen; K F Ng; T Kuo
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

2.  MRI findings of uncommon non-hepatocyte origin primary liver tumours with pathological correlation.

Authors:  Y C Kim; M-S Park; Y E Chung; M-J Kim; Y N Park; J-H Kang; K A Kim; K W Kim
Journal:  Br J Radiol       Date:  2010-10-05       Impact factor: 3.039

3.  MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.

Authors:  Y Maetani; K Itoh; C Watanabe; T Shibata; F Ametani; H Yamabe; J Konishi
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

4.  Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

Authors:  Kathryn J Fowler; Arman Sheybani; Rex A Parker; Sean Doherty; Elizabeth M Brunt; William C Chapman; Christine O Menias
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

5.  Hilar cholangiocarcinoma: comparative study with sonography and CT.

Authors:  B I Choi; J H Lee; M C Han; S H Kim; J G Yi; C W Kim
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

6.  Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.

Authors:  Anthony W H Chan; Joanna H M Tong; Mandy Y M Sung; Paul B S Lai; Ka-Fai To
Journal:  Histopathology       Date:  2014-09-02       Impact factor: 5.087

Review 7.  Magnetic resonance imaging of cholangiocarcinoma.

Authors:  Riccardo Manfredi; Brunella Barbaro; Gabriele Masselli; Amorino Vecchioli; Pasquale Marano
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

8.  Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation.

Authors:  P R Ros; J L Buck; Z D Goodman; A M Ros; W W Olmsted
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

9.  Peripheral cholangiocarcinoma: sonographic evaluation.

Authors:  B Wibulpolprasert; T Dhiensiri
Journal:  J Clin Ultrasound       Date:  1992-06       Impact factor: 0.910

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  5 in total

Review 1.  Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Authors:  Myeong-Jin Kim; Sunyoung Lee; Chansik An
Journal:  Eur Radiol       Date:  2019-02-20       Impact factor: 5.315

2.  Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma.

Authors:  Lei Wang; Hui Dong; Shujuan Ni; Dan Huang; Cong Tan; Bin Chang; Weiqi Sheng
Journal:  Oncotarget       Date:  2016-10-25

3.  Ultrasonographic findings of intrahepatic lymphoepithelioma-like cholangiocarcinoma associated with Epstein-Barr virus: Two cases report.

Authors:  Wenwu Ling; Changli Lu; He Huang; Tingting Qiu; Qiang Lu; Chengwu Huang; Ping Gong; Yan Luo; Shigao Chen
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

4.  Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience.

Authors:  Brandon Swed; Omar Gandarilla; Kenrry Chiu; Karim H Halazun; Benjamin Samstein; Rhonda Yantiss; Gagandeep Brar
Journal:  Case Reports Hepatol       Date:  2021-04-21

Review 5.  Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review.

Authors:  Kai Zhang; Changcheng Tao; Zonggui Tao; Fan Wu; Songlin An; Jianxiong Wu; Weiqi Rong
Journal:  Diagn Pathol       Date:  2020-09-23       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.